UNITED STATES SECURITIES AND EXCHANGE COMMISSION vs Pacific Proton Therapy Regional Center

Views: 4768

PlaintiffsDefendants

Preview sec
UNITED STATES SECURITIES AND EXCHANGE COMMISSION

vs.

Preview 88a
Pacific Proton Therapy Regional Center

CHARLES C. LIU; XIN WANG a/k/a LISA WANG; BEVERLY PROTON CENTER, LLC f/k/a LOS ANGELES COUNTY PROTON THERAPY, LLC

Filing Date:May 26, 2016

Case:SEC vs. Charles C. Liu, Xin Wang a/k/a Lisa Wang, Pacific Proton Therapy Regional Center, Beverly Proton Center

Jurisdiction:Federal District Court for the Central District of California

Status:Pending

Civil / Criminal:Civil

Cause(s) of Action:

Fraud

Description:

This case involves an ongoing fraudulent scheme perpetrated by defendant Charles C. Liu (“Liu”) and his wife, defendant Xin Wang, a/k/a Lisa Wang (“Wang”), to defraud Chinese investors in the federal “EB-5 Immigrant Investor Program,” which is administered by the United States Citizenship and Immigration Service (“USCIS”). To date, the defendants have defrauded at least 50 Chinese investors of almost $27 million by falsely claiming that their monies would be invested in a program that met the requirements of the EB-5 program, and would be used to build and operate a proton therapy cancer treatment center in Southern California.

Files
Jun
02
2016

SEC Complaint

SEC Complaint

comp-pr2016-105.pdf
Jun
04
2016

USCIS Approval Notice Pacific Proton Therapy RC with comments

USCIS Approval Notice Pacific Proton Therapy RC with comments

uscisapprovalnoticepacificprotontherapywithcomm...
Nov
15
2016

UNITED STATES DISTRICT COURT for the CENTRAL DISTRICT OF CALIFORNIA (Southern Division-Santa Ana) CIVIL DOCKET FOR CASE #: 8:16-cv-00974-CJC-AGR

UNITED STATES DISTRICT COURT for the CENTRAL DISTRICT OF CALIFORNIA (Southern Division-Santa Ana) CIVIL DOCKET FOR CASE #: 8:16-cv-00974-CJC-AGR

secv-161112020932.docx
Jul
11
2016

Preliminary Injunction against all defendants

Preliminary Injunction against all defendants

secv-160813200113.pdf
Feb
24
2017

SEC v. CHARLES C. LIU (PACIFIC PROTON), No. 16-00974 (C.D, CA 2-24-2017) PROPOSED SETTLEMENT

SEC v. CHARLES C. LIU (PACIFIC PROTON), No. 16-00974 (C.D, CA 2-24-2017) PROPOSED SETTLEMENT

secv-170306051826.pdf
Feb
06
2017

SEC v. Charles C. Liu et al (C.D. CA Feb. 6, 2017) (receivership & new briefs due soon)

SEC v. Charles C. Liu et al (C.D. CA Feb. 6, 2017) (receivership & new briefs due soon)

secv-170207032126.pdf
Jun
23
2020

CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT

Petitioners Charles Liu and his wife, Xin (Lisa) Wang, solicited nearly $27 million from foreign investors under the EB–5 Immigrant Investor Program (EB–5 Program). 754 Fed. Appx. 505, 506 (CA9 2018) (case below).

18-1501_8n5a.pdf
Attorneys, Regional Centers and Firms
Pacific Proton Therapy Regional Center, LLCUNITED STATES SECURITIES AND EXCHANGE COMMISSIONCharles LiuJohn W. BerryPacific Proton Therapy Regional Center

News & Updates

SEC Halts EB-5 Scheme Stealing Investments in Cancer Center
June 02, 2016
SEC: Couple Used Funds for Cancer Center as ‘Personal Piggy Bank’
June 03, 2016
Grenada promises to cooperate after US charges Chinese investors with fraud
June 04, 2016
Missing cancer center: SEC files fraud charges against Laguna Niguel couple
June 07, 2016
Grenada government expects no negative fallout from fraud charges against economic citizen
June 09, 2016
Grenada envisions no fallout from investor civil suit
June 10, 2016
Congress Eyes Reforms to Program That Offers US Visas to Foreign Investors
June 20, 2016
Couple Fights SEC's $65M Penalty Bid In EB-5 Fraud Row
February 16, 2017
SEC Says Couple Blew Chance To Settle EB-5 Fraud Suit
March 22, 2017
Couple charged in US with fraud in investor visa scheme
June 03, 2016
Father-daughter duo accused on $50 million EB-5 scam
April 14, 2017
Couple Must Repay $27M In EB-5 Cancer Center Fraud Scam
April 21, 2017
Supreme Court will consider stripping SEC of power to seize illegal profits
November 01, 2019
U.S. Supreme Court to review SEC's power to recover ill-gotten gains
November 02, 2019
54 Chinese investors defrauded in cancer treatment scam continue to go after law firm that prepared project documents
November 08, 2019
Can the S.E.C. Force Repayment of Ill-Gotten Gains?
November 29, 2019
Status Quo? Supreme Court to Decide SEC's Disgorgement Authority
March 05, 2020
Oral Argument Suggests Disgorgement May Survive Supreme Court Review in Liu v. SEC
March 04, 2020
SEC Disgorgement: Who Gets the Money?
March 12, 2020
US Supreme Court Leans Towards Approval of SEC’s Disgorgement Powers in Cases of Fraud
March 20, 2020
In Liu v. SEC, Supreme Court Upholds – But Limits – SEC’s Ability to Obtain Disgorgement, Leaving Many Questions for Lower Courts to Decide
June 26, 2020
SEC Disgorgement Lives to See Another Day After Supreme Court's Liu v. SEC Ruling
June 30, 2020
SEC Wins Fight to Retain Disgorgement Power But There's a Catch
July 02, 2020
After High Court's Liu Ruling, Calif. Co. Seeks SEC Relief
July 07, 2020
Ninth Circuit Reverses and Remands District Court Decision on Remedies
August 07, 2020
Ninth Circuit Reverses SEC Disgorgement Award and Remands in First Decision Post-Liu
August 21, 2020

Back


Securities Disclaimer

This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.